133 related articles for article (PubMed ID: 11353600)
1. Naltrexone as a treatment of self-injurious behavior: a case report.
Griengl H; Dantendorfer K
Eur Psychiatry; 2001 Apr; 16(3):193-4. PubMed ID: 11353600
[No Abstract] [Full Text] [Related]
2. Naltrexone treatment for a 3-year-old boy with self-injurious behavior.
White T; Schultz SK
Am J Psychiatry; 2000 Oct; 157(10):1574-82. PubMed ID: 11007709
[No Abstract] [Full Text] [Related]
3. Naltrexone as a treatment of self-injurious behavior--a case report.
Griengl H; Sendera A; Dantendorfer K
Acta Psychiatr Scand; 2001 Mar; 103(3):234-6. PubMed ID: 11240582
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of naltrexone on self-injurious behavior.
Sandman CA; Hetrick W; Taylor DV; Marion SD; Touchette P; Barron JL; Martinezzi V; Steinberg RM; Crinella FM
Am J Ment Retard; 2000 Mar; 105(2):103-17. PubMed ID: 10755174
[TBL] [Abstract][Full Text] [Related]
5. Naltrexone treatment of self-injurious behavior.
Godart NT; Agman G; Perdereau F; Jeammet P
J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1076-8. PubMed ID: 10986803
[No Abstract] [Full Text] [Related]
6. Naltrexone for Self-Injury in Borderline Personality With Venlafaxine-Associated Hyponatremia.
DeLucia B
J Clin Psychopharmacol; 2017 Dec; 37(6):743-745. PubMed ID: 28891834
[No Abstract] [Full Text] [Related]
7. [Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments].
Schmahl C; Bohus M
Nervenarzt; 2000 May; 71(5):427. PubMed ID: 10846724
[No Abstract] [Full Text] [Related]
8. The use of opiate antagonists for recurrent self-injurious behavior.
Buzan RD; Thomas M; Dubovsky SL; Treadway J
J Neuropsychiatry Clin Neurosci; 1995; 7(4):437-44. PubMed ID: 8555746
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone and self-injurious behavior: a retrospective population study.
Casner JA; Weinheimer B; Gualtieri CT
J Clin Psychopharmacol; 1996 Oct; 16(5):389-94. PubMed ID: 8889912
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone treatment of dementia with severe self-injurious behaviors: a single case study.
Vance HB; Kauffmann C; Pumariega AJ; Del Mundo A
Psychiatry; 2000; 63(3):288-99. PubMed ID: 11125673
[TBL] [Abstract][Full Text] [Related]
11. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
Roth AS; Ostroff RB; Hoffman RE
J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities.
Rana F; Gormez A; Varghese S
Cochrane Database Syst Rev; 2013 Apr; (4):CD009084. PubMed ID: 23633366
[TBL] [Abstract][Full Text] [Related]
13. Clinical uses of naltrexone: a review of the evidence.
Modesto-Lowe V; Van Kirk J
Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
[TBL] [Abstract][Full Text] [Related]
14. Using analog baselines to assess the effects of naltrexone on self-injurious behavior.
Garcia D; Smith RG
Res Dev Disabil; 1999; 20(1):1-21. PubMed ID: 9987807
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
[TBL] [Abstract][Full Text] [Related]
16. [Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders].
Bolm T; Piegler T
Psychiatr Prax; 2001 Jul; 28(5):214-8. PubMed ID: 11479827
[TBL] [Abstract][Full Text] [Related]
17. Preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults who have developmental disabilities.
Symons FJ; Sutton KA; Bodfish JW
Am J Ment Retard; 2001 Jul; 106(4):336-43. PubMed ID: 11414874
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities: Abridged republication of a Cochrane systematic review.
Gormez A; Rana F; Varghese S
J Psychopharmacol; 2014 Jul; 28(7):624-32. PubMed ID: 24785762
[TBL] [Abstract][Full Text] [Related]
19. Resolved: autistic children should have a trial of naltrexone.
Campbell M; Harris JC
J Am Acad Child Adolesc Psychiatry; 1996 Feb; 35(2):246-9; discussion 249-51. PubMed ID: 8720635
[No Abstract] [Full Text] [Related]
20. The use of depot naltrexone under legal coercion: the case for caution.
Hall W; Capps B; Carter A
Addiction; 2008 Dec; 103(12):1922-4. PubMed ID: 19469728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
